BlackRock’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Sell
150,088
-28,232
-16% -$241K ﹤0.01% 4249
2026
Q1
$980K Buy
178,320
+4,710
+3% +$52.1K ﹤0.01% 4354
2025
Q4
$4.58M Buy
173,610
+110,277
+174% +$2.13M ﹤0.01% 3870
2025
Q3
$1.21M Sell
63,333
-10,559
-14% -$164K ﹤0.01% 4240
2025
Q2
$1.44M Sell
73,892
-130,766
-64% -$2.54M ﹤0.01% 4148
2025
Q1
$2.92M Sell
204,658
-2,312
-1% -$44.3K ﹤0.01% 3872
2024
Q4
$5.12M Buy
206,970
+20,927
+11% +$585K ﹤0.01% 3722
2024
Q3
$5.65M Buy
186,043
+152,193
+450% +$5.96M ﹤0.01% 3646
2024
Q2
$1.73M Buy
33,850
+31,701
+1,475% +$2.45M ﹤0.01% 4004
2024
Q1
$191K Buy
+2,149
New +$217K ﹤0.01% 4593

Other funds holding GUTS

BlackRock's GUTS Position: Q2 2026 in Review

BlackRock reduced its Fractyl Health (GUTS) stake by 16% in Q2 2026, selling an estimated $241K and leaving 150,088 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

BlackRock first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.65M in Q3 2024. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • BlackRock held 150,088 shares of Fractyl Health worth $1.43M as of Q2 2026.
  • BlackRock sold 28,232 Fractyl Health shares in Q2 2026, an estimated $241K.
  • Fractyl Health made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4249 holding.
  • BlackRock first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • BlackRock's Fractyl Health position peaked at $5.65M in Q3 2024.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.